471
IRUS Total
Downloads
  Altmetric

Allogeneic transplantation for CML in the TKI era: striking the right balance

File Description SizeFormat 
Revised submission full.docxAccepted version536.7 kBMicrosoft WordView/Open
Title: Allogeneic transplantation for CML in the TKI era: striking the right balance
Authors: Innes, AJ
Milojkovic, D
Apperley, JF
Item Type: Journal Article
Issue Date: 1-Feb-2016
URI: http://hdl.handle.net/10044/1/54171
DOI: https://dx.doi.org/10.1038/nrclinonc.2015.193
ISSN: 1759-4774
Publisher: NATURE PUBLISHING GROUP
Start Page: 79
End Page: 91
Journal / Book Title: NATURE REVIEWS CLINICAL ONCOLOGY
Volume: 13
Issue: 2
Copyright Statement: Copyright © 2015, Rights Managed by Nature Publishing Group
Sponsor/Funder: Imperial College Trust
Leuka
Leuka
National Institute for Health Research
Funder's Grant Number: 070904JA
na
Renew P45896 Core Grant 2014
NF-SI-0611-10275
Keywords: Science & Technology
Life Sciences & Biomedicine
Oncology
CHRONIC MYELOID-LEUKEMIA
STEM-CELL TRANSPLANTATION
CHRONIC MYELOGENOUS LEUKEMIA
TYROSINE KINASE INHIBITORS
BONE-MARROW-TRANSPLANTATION
VERSUS-HOST-DISEASE
CHRONIC GRANULOCYTIC-LEUKEMIA
ACUTE LYMPHOBLASTIC-LEUKEMIA
CORD BLOOD TRANSPLANTATION
BCR-ABL TRANSCRIPTS
Chemotherapy, Adjuvant
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Transplantation Conditioning
Transplantation, Homologous
Publication Status: Published
Appears in Collections:Department of Medicine (up to 2019)